Expired activity
Please go to the PowerPak homepage and select a course.

Squashing the Common Head Lice Myths: Update on Eradication and Resistance Patterns

This activity is jointly provided by Postgraduate Institute for Medicine and Postgraduate Healthcare Education, LLC (PHE).
This activity is supported by an independent educational grant from ParaPRO.

FACULTY

Leon Kircik, MD
Clinical Associate Professor 
Icahn School of Medicine at Mount Sinai, NY
Indiana Medical Center, Indianapolis, IN
Medical Director
Physicians Skin Care, PLLC, Louisville, KY
DermResearch, PLLC, Louisville, KY

MEDICAL WRITER

Katherine Wandersee

FINANCIAL DISCLOSURE

Leon Kircik, MD states the following relevant affiliations or financial relationships with a commercial interest related to the content of this activity: Contracted Research – Bayer HealthCare Pharmaceuticals and Consulting Fees - Taro.

The following reviewer, Steven Kheloussi, PharmD, hereby states that he does not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Susanne Batesko, RN, BSN, and Robin Carrino, Katherine Wandersee, as well as the planners, managers, and other individuals, not previously disclosed, who are in a position to control the content of Postgraduate Healthcare Education (PHE) continuing education (CE) activities hereby state that they have no relevant conflicts of interest and no financial relationships or relationships to products or devices during the past 12 months to disclose in relation to this activity. We are committed to providing participants with a quality learning experience and to improve clinical outcomes without promoting the financial interests of a proprietary business.

The following PIM planners and managers, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, Judi Smelker-Mitchek, RN, BSN and Jan Schultz, RN, MSN, CHCP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

ACCREDITATION STATEMENTS

PHARMACY
acpe Postgraduate Healthcare Education, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
UAN: 0430-9999-16-078-H01-P
Credits: 2.0 hours (0.20 ceu)

Published: July 29, 2016
Expires: July 31, 2018
Type of Activity: Knowledge
Media: Internet

Fee Information: There is no fee for this educational activity.

Estimated time to complete activity: 120 minutes

Physician Continuing Medical Education

Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and Postgraduate healthcare Education, LLC. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education

Credit Designation
This educational activity for 2.0 contact hours is provided by Postgraduate Institute for Medicine.

Accreditation Statement
Postgraduate Institute for Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

TARGET AUDIENCE

This activity has been designed to meet the educational needs of pharmacists, physicians and registered nurses involved in the care of patients with head lice.

HOW TO OBTAIN CREDIT

During the period July 29, 2016 through July 31, 2018, participants must 1) read the learning objectives and faculty disclosures; 2) view the educational activity; and 3) complete the post-test and the evaluation form. To answer the questions, click on your selected choice for each answer then proceed to the next question. Once completed, click on Grade Exam at the bottom of the page. Your post-test will automatically be graded. If you successfully complete the post-test (score of 70% or higher), your statement of participation will be made available immediately. Click on the View Statement of Participation link and print the statement for your records. If you receive a score lower than 70%, you will receive a message notifying you that you did not pass the post-test. You will have 2 opportunities to pass the post-test. To receive pharmacy Credit, you must provide your date of birth and NABP number. All Credit information will be uploaded into CPE monitor within 30 days.

GOAL

To provide healthcare providers (HCPs) in a variety of disciplines and practice settings with the most current and scientifically accurate information about head lice infestation, spread, and management, including the impact of resistant strains on louse eradication.

EDUCATIONAL OBJECTIVES

Upon completion of this activity, participants should be better able to:

  1. Describe current U.S. data on head lice resistance patterns and the implications of resistance on pediculosis treatment effectiveness in the community.
  2. Apply current approaches to head lice management using the latest scientific knowledge about diagnosis, spread, and eradication.
  3. Identify FDA-approved pediculicides and discuss their dosage, administration, safety issues, and rationale.
  4. Describe clinical data and appropriate administration of newly introduced treatments for head lice.
  5. Educate interested audiences and debunk common myths about head lice prevention, proliferation, and eradication.

REQUIRED COMPUTER HARDWARE/SOFTWARE

Please ensure the computer you plan to use meets the following minimum requirements:

  • Operating System: Windows 98 or higher & Macintosh 2.2 or higher
  • Internet Browser (Mac &/ Windows): Internet Explorer 6.0 or higher, Google Chrome, Safari 5.0.6 or higher, Firefox 3.0.3 or higher & Opera 5 or higher
  • Broadband Internet connection: Cable, High-speed DSL & any other medium that is internet accessible
  • Monitor Screen Resolution: 320 x 480 or higher
  • Media Viewing Requirements: Adobe Reader, Microsoft Powerpoint, Flash Player & HTML5

DISCLOSURE OF UNLABELED USE AND DISCLAIMER

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Postgraduate Healthcare Education, LLC, PIM and ParaPRO. Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without an evaluation of their patients' conditions and current medications, including the identification of possible contraindications regarding the dangers of use and a review of any applicable manufacturer's product information, as well as a comparison with the recommendations of other authorities.

The author, joint sponsors, and publisher of this continuing education activity have made all reasonable efforts to ensure that all information contained herein is accurate in accordance with the latest available scientific knowledge at the time of acceptance for publication. However, because information regarding drugs (their administration, dosages, contraindications, adverse reactions, interactions, special warnings, precautions, etc.) is subject to constant change, the reader is advised to check the manufacturer's package insert for information concerning recommended dosages and potential problems and cautions prior to dispensing or administering the drug. Special precautions should be taken when a drug is new, or highly toxic, or is unfamiliar to the dispenser or administrant. This educational activity may contain discussion of published and/or investigational uses of agents that are not approved by the U.S. Food and Drug Administration (FDA). Neither the publisher nor sponsor promotes the use of any agent outside of approved labeling. Statements made in this monograph have not been evaluated by the FDA. Nutritional products discussed are not intended for the diagnosis, treatment, cure, or prevention of any disease.